These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 134464)

  • 1. The anticoagulant effect of heparan sulfate and dermatan sulfate.
    Teien AN; Abildgaard U; Höök M
    Thromb Res; 1976 Jun; 8(6):859-67. PubMed ID: 134464
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
    Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
    Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation protein function: enhancement of the anticoagulant effect of acetaldehyde by sulfated glycosaminoglycans.
    Brecher AS; Adamu MT
    Dig Dis Sci; 2001 Sep; 46(9):2033-42. PubMed ID: 11575460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways.
    Ofosu FA; Modi GJ; Smith LM; Cerskus AL; Hirsh J; Blajchman MA
    Blood; 1984 Sep; 64(3):742-7. PubMed ID: 6235872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of glycosaminoglycans on the growth of cultured tumor cells.
    Nagasawa S
    J Osaka Dent Univ; 1993 Oct; 27(2):121-33. PubMed ID: 8182504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis.
    Chang X; Yamada R; Yamamoto K
    Arthritis Res Ther; 2005; 7(2):R268-73. PubMed ID: 15743473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic effect of sulphated and nonsulphated glycosaminoglycans and polysaccharides in the chick embryo chorioallantoic membrane.
    Hahnenberger R; Jakobson AM
    Glycoconj J; 1991 Aug; 8(4):350-3. PubMed ID: 1726778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate.
    Ofosu FA; Modi GJ; Blajchman MA; Buchanan MR; Johnson EA
    Biochem J; 1987 Dec; 248(3):889-96. PubMed ID: 2963622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glycosaminoglycans on thrombin-induced clotting of normal and antithrombin III-deficient plasmas.
    Kindness G; Long WF; Williamson FB; Edward M; Winter JH; Bennett NB
    Thromb Res; 1980 Feb 1-15; 17(3-4):539-44. PubMed ID: 6768163
    [No Abstract]   [Full Text] [Related]  

  • 11. Glycosaminoglycans enhance human leukemic cell growth in vitro.
    Maurer AM; Han ZC; Dhermy D; Brière J
    Leuk Res; 1994 Nov; 18(11):837-42. PubMed ID: 7967710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
    Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
    Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
    J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C.
    Fernández JA; Petäjä J; Griffin JH
    Thromb Haemost; 1999 Nov; 82(5):1462-8. PubMed ID: 10595639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of heparin cofactor II by dermatan sulfate.
    Tollefsen DM; Pestka CA; Monafo WJ
    J Biol Chem; 1983 Jun; 258(11):6713-6. PubMed ID: 6687888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acidic glycosaminoglycans in human aortic inner and outer layers on partial thromboplastin time.
    Murata K; Izuka K; Nakazawa K
    Atherosclerosis; 1978 Jan; 29(1):95-104. PubMed ID: 629829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin cofactor II activation by dermatan sulfate.
    Tollefsen DM; Maimone MM; McGuire EA; Peacock ME
    Ann N Y Acad Sci; 1989; 556():116-22. PubMed ID: 2660682
    [No Abstract]   [Full Text] [Related]  

  • 19. One dimensional thin-layer cellulose chromatographic separation of dermatan-, heparan-, chondroitin- and keratan sulfate.
    Wang TR
    Taiwan Yi Xue Hui Za Zhi; 1984 Aug; 83(8):737-42. PubMed ID: 6240525
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of various glycosaminoglycans upon cAMP-dependent protein kinase.
    Dittmann J; Krischek C; Harisch G
    Cell Biochem Funct; 1999 Mar; 17(1):21-8. PubMed ID: 10191505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.